Product Program year 2025 Source: CMS Open Payments

EMPOWER Leadless Pacemaker System_CRM

Device EMPOWER Leadless Pacemaker System_CRM

Open in the dashboard

General payments

$3,268

76 payments

Research payments

$0

0 payments

Through program year 2025, $3,268 in general payments and $0 in research payments were reported against EMPOWER Leadless Pacemaker System_CRM (EMPOWER Leadless Pacemaker System_CRM).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $3,268 76

Breakdown

Who paid General payments · program year 2025
  1. Boston Scientific Corporation $3,268 76 payments
Top recipients General payments · program year 2025
  1. Saarik Gupta Cardiovascular Disease · Santa Monica, CA $158 5% · 2 payments
  2. Jeffrey Gordon Clinical Cardiac Electrophysiology · Allentown, PA $143 4% · 2 payments
  3. Hamid Sattar Cardiovascular Disease · Dearborn, MI $117 4% · 1 payment
  4. David Benditt Cardiovascular Disease · St Cloud, MN $107 3% · 1 payment
  5. Markus Meyer Cardiovascular Disease · Minneapolis, MN $107 3% · 1 payment

The top 5 of 65 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $1,247 38% · 25 practitioners
  2. Cardiovascular Disease Internal Medicine $1,029 32% · 15 practitioners
  3. Internal Medicine $221 7% · 5 practitioners
  4. Nurse Practitioner $192 6% · 5 practitioners
  5. Physician Assistant $188 6% · 4 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Minnesota $966 30% · 9 recipients
  2. Michigan $431 13% · 7 recipients
  3. California $322 10% · 5 recipients
  4. Pennsylvania $264 8% · 4 recipients
  5. Utah $235 7% · 6 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

76 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record